ALLO
Allogene Therapeutics Inc
1.50$
-2.6%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | – | 100.0% | – | – | – | – | – | – | – | – | 100.0% | 100.0% | |
| 16,236.4% | – | 16,159.1% | – | – | – | – | – | – | – | – | – | – | |
| -16,136.4% | – | -16,059.1% | – | – | – | – | – | – | – | – | 100.0% | -699.4% | |
| 208,986.4% | – | 237,540.9% | – | – | – | – | – | – | – | – | 662.1% | 2,578.7% | |
| 77,459.1% | – | 78,486.4% | – | – | – | – | – | – | – | – | 449.1% | 1,345.6% | |
| 270,209.1% | – | 299,868.2% | – | – | – | – | – | – | – | – | 1,111.2% | 3,186.8% | |
| -286,345.5% | – | -315,927.3% | – | – | – | – | – | – | – | – | -1,011.2% | -3,886.1% | |
| 0.0% | – | 0.0% | – | – | – | – | – | – | – | – | 7.4% | 28.0% | |
| -283,122.7% | – | -295,454.5% | – | – | – | – | – | – | – | – | -919.8% | -3,566.7% | |
| -28,204.5% | – | 15,962.4% | – | – | – | – | – | – | – | – | – | – | |
| -283,122.7% | – | -295,454.5% | – | – | – | – | – | – | – | – | -919.8% | -3,566.7% | |
| -266,886.4% | – | -279,295.5% | – | – | – | – | – | – | – | – | -855.4% | -3,287.2% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.